Akhilesh Pandey, M.D., Ph.D.

Wu, X., Zahari, M. S., Renuse, S., Kelkar, D. S., Barbhuiya, M. A., Rojas, P. L., Stearns, V., Gabrielson, E., Malla, P., Sukumar, S., Mahajan, N. P. and Pandey, A. (2017). The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer. Oncotarget. 8, 2971-2983. [PubMed]